Premium
Mitochondria: Aspects for neuroprotection
Author(s) -
Hart Paul E.,
Schapira Anthony H.V.
Publication year - 1999
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/(sici)1098-2299(199901)46:1<57::aid-ddr9>3.0.co;2-r
Subject(s) - neuroprotection , mitochondrial dna , mitochondrion , mitochondrial disease , biology , neuroscience , disease , genetics , medicine , pathology , gene
The understanding of mitochondrial biology and, subsquently, the role of mitochondrial pathology in human disease has increased exponentially over the past 30 years. As insight has increased, so attention has begun to shift to the possibilities for treating mitochondrially based disorders. There are a number of archetypal mitochondrial diseases, each associated with specific mitochondrial DNA mutations, deletions, or depletions. In addition there are a number of disorders, mainly neurodegenerative in nature, in which mitochondrial dysfunction appears to play a pivotal role. Mitochondrial structure and function are discussed. Treatment of the archetypal mitochondrial disorders and other neurogenerative conditions is reviewed, with specific emphasis on the prospects for neuroprotection. Drug Dev. Res. 46:57–66, 1998. © 1998 Wiley‐Liss, Inc.